Compare HROW & VSTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | HROW | VSTS |
|---|---|---|
| Founded | 1998 | 1936 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.9B |
| IPO Year | 2008 | 2023 |
| Metric | HROW | VSTS |
|---|---|---|
| Price | $39.48 | $13.41 |
| Analyst Decision | Strong Buy | Sell |
| Analyst Count | 8 | 4 |
| Target Price | ★ $69.86 | $5.88 |
| AVG Volume (30 Days) | 550.4K | ★ 1.4M |
| Earning Date | 05-11-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 71.43 | N/A |
| EPS | N/A | ★ 0.05 |
| Revenue | N/A | ★ $2,734,839,000.00 |
| Revenue This Year | $31.62 | N/A |
| Revenue Next Year | $50.77 | $1.67 |
| P/E Ratio | ★ N/A | $266.60 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $28.54 | $3.98 |
| 52 Week High | $54.98 | $16.90 |
| Indicator | HROW | VSTS |
|---|---|---|
| Relative Strength Index (RSI) | 49.09 | 37.38 |
| Support Level | $37.03 | $13.40 |
| Resistance Level | $41.82 | $13.58 |
| Average True Range (ATR) | 1.80 | 0.64 |
| MACD | -0.00 | -0.19 |
| Stochastic Oscillator | 49.15 | 17.91 |
Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company partners with U.S. eyecare professionals to develop products used to manage ophthalmic conditions affecting both the front and back of the eye, such as dry eye disease, cataracts, refractive errors, glaucoma, etc. Its portfolio of branded ophthalmic pharmaceuticals includes Iheezo, Vevye, Byooviz Opuviz, Natacyn, Maxitrol, Maxidex, etc. Additionally, the company's development pipeline comprises candidates like MELT-300, H-N08, CR-01, and MELT-210, being developed to address unmet needs in eye care and selected adjacent markets. Its reportable segments are: Branded, which derives maximum revenue, and ImprimisRx.
Vestis Corp is a provider of uniform rentals and workplace supplies across the United States and Canada. It provides uniforms, mats, towels, linens, restroom supplies, first-aid supplies, safety products, and other workplace supplies. The Company serves customers ranging from small, family-owned operations with a single location to large corporations and national franchises with multiple locations. The company operates in the United States and Canada as reportable segments. The company earns the majority of its revenue from the United States.